TMEM191A (Gene)

Entrez:84222

Description:transmembrane protein 191A (pseudogene)

Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View TMEM191A's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with TMEM191A.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using TMEM191A.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for TMEM191A.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with TMEM191A.

Results found

Linked to

	Label	Description
	GSE108464 AZ-628 6 v 13 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE198930 prunetin AGS 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE212231 GSE218491 SHP2 inhibition 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE201309 matrine 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE207376 GSE207377 nutlin-3 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE138219 ROS knockdown 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE115384 CELSR2 knockdown 6 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE147876 GSE147877 enzalutamide MR42D 4 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE130715 budesonide muscle organ 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE221329 ERK BRAF inhibition thyroid gland 1 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS

GSE108464 AZ-628 6 v 13 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE198930 prunetin AGS 1 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE212231 GSE218491 SHP2 inhibition 2 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE201309 matrine 1 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE207376 GSE207377 nutlin-3 0 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE138219 ROS knockdown 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE115384 CELSR2 knockdown 6 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE147876 GSE147877 enzalutamide MR42D 4 v 5 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE130715 budesonide muscle organ 2 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE221329 ERK BRAF inhibition thyroid gland 1 v 7 human up

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.